Breast cancer screening: ages 40 to 74, every 2 years
A mammogram every 2 years from 40 to 74 (USPSTF grade B, 2024). The USPSTF lowered the starting age from 50 to 40 in 2024, and from 75 it found the evidence insufficient to decide. Other groups differ on how often, some advising yearly mammograms at some ages; your doctor decides with you. (USPSTF, 2024) More: how often, by guideline.
- USPSTF grade
- B
- Who
- Women
- Ages
- 40 to 74
- How often
- Every 2 years
When it starts, when it can stop
- Starts: At 40 (lowered from 50 in 2024). (USPSTF, 2024)
- Can stop: The grade B range ends at 74. For women 75 or older the USPSTF says the evidence is not enough to decide (grade I). (USPSTF, 2024)
Who it is for
Women aged 40 to 74 years at average risk. (USPSTF, 2024)
The USPSTF advice does not cover people with a genetic marker or syndrome linked to high breast cancer risk (such as a BRCA1 or BRCA2 variant), high-dose chest radiation at a young age, a past breast cancer, or a high-risk lesion on an earlier biopsy. They need a screening plan made with their clinician. (USPSTF, 2024)
Test and how often
- A screening mammogram every 2 years (biennial). (USPSTF, 2024)
How often to get a mammogram, by guideline
| Age | USPSTF (2024) | American Cancer Society | ACOG |
|---|---|---|---|
| 40 to 44 | Every 2 years | Option to start yearly mammograms | Every 1 to 2 years |
| 45 to 54 | Every 2 years | Every year | Every 1 to 2 years |
| 55 to 74 | Every 2 years | Every 2 years, or keep going yearly | Every 1 to 2 years |
| 75 and older | Evidence insufficient (I) | Continue while in good health and expected to live at least 10 more years | Continue until at least 75 |
The USPSTF recommends every 2 years from 40 to 74, and says the evidence suggests that screening every 2 years has a more favorable trade-off of benefits and harms than yearly screening. (USPSTF, 2024)
The American Cancer Society gives women 40 to 44 the option of a yearly mammogram, advises yearly mammograms from 45 to 54, and lets women 55 and older switch to every other year or stay yearly, continuing as long as they are in good health and expected to live at least 10 more years. (ACS, 2026)
ACOG recommends a mammogram every 1 to 2 years from 40 for women at average risk, continuing until at least 75, and suggests asking your doctor about the pros and cons of every 2 years instead of every year. (ACOG)
Medicare Part B pays for a screening mammogram once every 12 months for women 40 and older, so a yearly schedule is covered. (Medicare.gov)
These schedules are for women at average risk. People at high risk, such as those with a BRCA gene change, follow a different plan with their doctor. Read more: BRCA risk assessment. (ACS, 2026)
The bodies weigh the same trade-off differently. Which interval fits you is a decision to make with your doctor. Read more: cancer screening guidelines compared.
Where the USPSTF draws the line
Grade C means a small net benefit, so it is offered to some people; D means do not screen; I means the evidence is not enough to decide. (USPSTF grade definitions)
- Grade I: the evidence is not enough to weigh benefits and harms of mammograms for women 75 or older. (USPSTF, 2024)
- Grade I: the evidence is not enough to weigh extra screening with ultrasound or MRI for women with dense breasts and an otherwise normal mammogram. (USPSTF, 2024)
Questions people ask
At what age should a woman get her first mammogram?
At 40, for women at average risk, then every 2 years. Before 2024 the USPSTF left screening in the 40s as an individual decision; its 2024 statement recommends it for everyone from 40. (USPSTF, 2024)
How often should you get a mammogram?
The USPSTF says every 2 years from 40 to 74, and that biennial screening "has a more favorable trade-off of benefits vs harms than annual screening." Other groups differ: the American Cancer Society advises yearly mammograms from 45 to 54, and ACOG says every 1 to 2 years from 40. Your doctor decides with you. (USPSTF, 2024) (ACS, 2026) (ACOG)
At what age can you stop getting mammograms?
The grade B range ends at 74. For women 75 or older the USPSTF says the evidence is "insufficient to assess the balance of benefits and harms" (grade I), so whether to keep going is a decision to make with your clinician, based on your health and preferences. (USPSTF, 2024)
Does this apply if breast cancer runs in my family?
Yes, if the family history is a first-degree relative (a parent, sibling or child) with breast cancer. The USPSTF says its advice also applies to people with that history or with dense breasts. It does not apply to people with a BRCA1 or BRCA2 variant or other high-risk factors listed above. If breast, ovarian, tubal or peritoneal cancer runs in your family, a separate USPSTF recommendation on BRCA risk assessment applies. Read more: BRCA risk assessment. (USPSTF, 2024)
I have dense breasts. Do I need an ultrasound or MRI too?
Women with dense breasts should still start mammograms at 40. The USPSTF found the evidence insufficient to recommend for or against extra screening with breast ultrasound or MRI after a normal mammogram, and says these women should talk to their clinicians about follow-up options. It also notes that since September 2024 the FDA requires mammography centers to tell patients about their breast density. (USPSTF, 2024)
Is a 3D mammogram better than a regular one?
The USPSTF says both digital mammography and digital breast tomosynthesis ("3D mammography") are effective for screening. The American Cancer Society says 3D mammography appears to lower the chance of being called back and to find more cancers, but often costs more and may not be covered by insurance. (USPSTF, 2024) (ACS, 2026)
Does Medicare pay for mammograms?
Medicare Part B covers a screening mammogram once every 12 months for women 40 or older, and one baseline mammogram between 35 and 39. You pay nothing for these if the provider accepts assignment. A diagnostic mammogram (to check a problem) costs 20% of the Medicare-approved amount after the Part B deductible. (Medicare.gov)
Are there medicines that lower breast cancer risk?
Yes, for some women. The USPSTF recommends offering medicines such as tamoxifen, raloxifene or an aromatase inhibitor to women 35 and older at increased risk of breast cancer, and not to women at average risk. Details and sources are on our page about these medicines. Read more: medicines to lower breast cancer risk. (USPSTF, 2024)
Source
U.S. Preventive Services Task Force, "Breast Cancer: Screening", final recommendation released April 30, 2024. Read it on uspreventiveservicestaskforce.org. Checked against the live page on 2026-10-30.
Related
- Build my screening plan
- All screenings by age and gender (printable PDF)
- Preventive screenings covered by insurance and Medicare
- Mammogram: what to expect, how to prepare, 3D vs 2D
- Screening and race or ethnicity: what guidelines say
- Cancer screenings by age: chart of every USPSTF statement
- Overdue or never screened? What still applies at your age
- Abnormal result? What usually happens next
- When can you stop screening? Ages by test
- No insurance? Free or low-cost screenings without insurance
- Family history: when screening starts earlier
- Screening guidelines compared: USPSTF, ACS, ACOG, ACP, AUA
- How the screening guidelines changed: dated timeline
- False positives and overdiagnosis, by test
- Mammogram results: BI-RADS 0 to 6 and callbacks explained
- Dense breasts on your mammogram report: what it means
- What tests are in an annual physical?
- Screenings at 40
- Screenings at 45
- Screenings at 50
- Screenings at 55
- Screenings at 60
- Screenings at 65
- Screenings at 70
- Screenings for women over 40
- Screenings for women over 50
- Screenings for women over 60
- Screenings for women over 65
- Screenings for women over 70